Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

Abstract

This study highlighted noteworthy intra-individual discordance in KRAS mutational status, whereas EGFR status was stable. Intratumoral heterogeneity for ALK rearrangement suggests a limitation of single-biopsy analysis for therapeutic strategy with crizotinib.